HEADER VIRAL PROTEIN 02-NOV-23 8WZP TITLE CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE M49I MUTANT IN COMPLEX TITLE 2 WITH CCF0058981 COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3C-LIKE PROTEINASE NSP5; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: 3CL-PRO,3CLP,MAIN PROTEASE,MPRO,NON-STRUCTURAL PROTEIN 5, COMPND 5 NSP5,SARS CORONAVIRUS MAIN PROTEINASE; COMPND 6 EC: 3.4.22.69; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_COMMON: 2019-NCOV, SARS-COV-2; SOURCE 5 ORGANISM_TAXID: 2697049; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS VIRAL PROTEIN-INHIBITOR COMPLEX, VIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR H.H.JIANG,X.F.ZOU,X.L.ZHOU,J.ZHANG,J.LI REVDAT 1 17-APR-24 8WZP 0 JRNL AUTH H.JIANG,X.ZOU,X.ZHOU,J.ZHANG,J.LI JRNL TITL CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE (M PRO ) JRNL TITL 2 MUTANTS IN COMPLEX WITH THE NON-COVALENT INHIBITOR JRNL TITL 3 CCF0058981. JRNL REF BIOCHEM.BIOPHYS.RES.COMMUN. V. 692 49352 2024 JRNL REFN ESSN 1090-2104 JRNL PMID 38056159 JRNL DOI 10.1016/J.BBRC.2023.149352 REMARK 2 REMARK 2 RESOLUTION. 1.76 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.12_2829 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.76 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.82 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.354 REMARK 3 COMPLETENESS FOR RANGE (%) : 82.9 REMARK 3 NUMBER OF REFLECTIONS : 48869 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.194 REMARK 3 R VALUE (WORKING SET) : 0.192 REMARK 3 FREE R VALUE : 0.236 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.764 REMARK 3 FREE R VALUE TEST SET COUNT : 2328 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 35.8200 - 4.5137 0.99 3299 182 0.1474 0.1930 REMARK 3 2 4.5137 - 3.5837 0.87 2901 156 0.1510 0.1831 REMARK 3 3 3.5837 - 3.1310 0.79 2603 129 0.1917 0.2623 REMARK 3 4 3.1310 - 2.8449 0.99 3317 141 0.2117 0.2129 REMARK 3 5 2.8449 - 2.6410 0.84 2776 140 0.2263 0.3236 REMARK 3 6 2.6410 - 2.4853 1.00 3301 145 0.2247 0.2340 REMARK 3 7 2.4853 - 2.3609 1.00 3314 175 0.2162 0.2806 REMARK 3 8 2.3609 - 2.2581 1.00 2992 161 0.2158 0.2615 REMARK 3 9 2.2581 - 2.1712 0.97 2208 125 0.2117 0.2688 REMARK 3 10 2.1712 - 2.0963 1.00 3311 161 0.2201 0.2489 REMARK 3 11 2.0963 - 2.0308 0.62 2038 106 0.2408 0.3116 REMARK 3 12 2.0308 - 1.9727 1.00 3261 177 0.2411 0.3100 REMARK 3 13 1.9727 - 1.9208 0.42 1262 70 0.2660 0.3187 REMARK 3 14 1.9208 - 1.8739 0.45 234 14 0.3753 0.4176 REMARK 3 15 1.8739 - 1.8313 0.96 3124 145 0.2810 0.3967 REMARK 3 16 1.8313 - 1.7924 1.00 3331 136 0.2820 0.3474 REMARK 3 17 1.7924 - 1.7600 1.00 3269 165 0.3121 0.3855 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.243 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 31.347 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.15 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.76 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 4694 REMARK 3 ANGLE : 0.819 6399 REMARK 3 CHIRALITY : 0.050 732 REMARK 3 PLANARITY : 0.006 832 REMARK 3 DIHEDRAL : 8.697 2741 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8WZP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBC ON 03-NOV-23. REMARK 100 THE DEPOSITION ID IS D_1300042333. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-JUL-23 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL02U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97918 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 S 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 48939 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.760 REMARK 200 RESOLUTION RANGE LOW (A) : 52.510 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.0 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : 0.06700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.76 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.85 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.72800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.69 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.26 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.12M-0.21M NA2SO4, 20%-24% PEG3350, REMARK 280 VAPOR DIFFUSION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 48.98000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2160 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24550 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY B 302 REMARK 465 VAL B 303 REMARK 465 VAL B 304 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 76 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 100 CG CD CE NZ REMARK 470 TYR A 154 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG A 223 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 279 CG CD NE CZ NH1 NH2 REMARK 470 LEU A 286 CG CD1 CD2 REMARK 470 GLU B 47 CG CD OE1 OE2 REMARK 470 GLN B 69 CG CD OE1 NE2 REMARK 470 ASN B 72 CG OD1 ND2 REMARK 470 ARG B 76 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 100 CG CD CE NZ REMARK 470 LYS B 102 CG CD CE NZ REMARK 470 LYS B 137 CG CD CE NZ REMARK 470 TYR B 154 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG B 223 CG CD NE CZ NH1 NH2 REMARK 470 ASP B 245 CG OD1 OD2 REMARK 470 ARG B 279 CG CD NE CZ NH1 NH2 REMARK 470 LEU B 286 CG CD1 CD2 REMARK 470 ARG B 298 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 33 -128.87 56.57 REMARK 500 ASN A 51 72.22 -156.91 REMARK 500 ASN A 84 -127.27 58.24 REMARK 500 PRO A 184 43.85 -93.47 REMARK 500 ALA A 191 108.44 -58.29 REMARK 500 ASP B 33 -129.15 55.73 REMARK 500 ASN B 51 73.98 -159.91 REMARK 500 ASN B 84 -125.48 53.19 REMARK 500 PRO B 184 37.62 -91.40 REMARK 500 REMARK 500 REMARK: NULL DBREF 8WZP A 3 304 UNP P0DTC1 R1A_SARS2 3266 3567 DBREF 8WZP B 3 304 UNP P0DTC1 R1A_SARS2 3266 3567 SEQADV 8WZP ILE A 49 UNP P0DTC1 MET 3312 ENGINEERED MUTATION SEQADV 8WZP ALA A 222 UNP P0DTC1 ARG 3485 CONFLICT SEQADV 8WZP ARG A 223 UNP P0DTC1 PHE 3486 CONFLICT SEQADV 8WZP VAL A 304 UNP P0DTC1 THR 3567 CONFLICT SEQADV 8WZP ILE B 49 UNP P0DTC1 MET 3312 ENGINEERED MUTATION SEQADV 8WZP ALA B 222 UNP P0DTC1 ARG 3485 CONFLICT SEQADV 8WZP ARG B 223 UNP P0DTC1 PHE 3486 CONFLICT SEQADV 8WZP VAL B 304 UNP P0DTC1 THR 3567 CONFLICT SEQRES 1 A 302 PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL GLU GLY SEQRES 2 A 302 CYS MET VAL GLN VAL THR CYS GLY THR THR THR LEU ASN SEQRES 3 A 302 GLY LEU TRP LEU ASP ASP VAL VAL TYR CYS PRO ARG HIS SEQRES 4 A 302 VAL ILE CYS THR SER GLU ASP ILE LEU ASN PRO ASN TYR SEQRES 5 A 302 GLU ASP LEU LEU ILE ARG LYS SER ASN HIS ASN PHE LEU SEQRES 6 A 302 VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL ILE GLY HIS SEQRES 7 A 302 SER MET GLN ASN CYS VAL LEU LYS LEU LYS VAL ASP THR SEQRES 8 A 302 ALA ASN PRO LYS THR PRO LYS TYR LYS PHE VAL ARG ILE SEQRES 9 A 302 GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS TYR ASN SEQRES 10 A 302 GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET ARG PRO SEQRES 11 A 302 ASN PHE THR ILE LYS GLY SER PHE LEU ASN GLY SER CYS SEQRES 12 A 302 GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS VAL SER SEQRES 13 A 302 PHE CYS TYR MET HIS HIS MET GLU LEU PRO THR GLY VAL SEQRES 14 A 302 HIS ALA GLY THR ASP LEU GLU GLY ASN PHE TYR GLY PRO SEQRES 15 A 302 PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY THR ASP SEQRES 16 A 302 THR THR ILE THR VAL ASN VAL LEU ALA TRP LEU TYR ALA SEQRES 17 A 302 ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN ALA ARG SEQRES 18 A 302 THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA MET LYS SEQRES 19 A 302 TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL ASP ILE SEQRES 20 A 302 LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA VAL LEU SEQRES 21 A 302 ASP MET CYS ALA SER LEU LYS GLU LEU LEU GLN ASN GLY SEQRES 22 A 302 MET ASN GLY ARG THR ILE LEU GLY SER ALA LEU LEU GLU SEQRES 23 A 302 ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN CYS SER SEQRES 24 A 302 GLY VAL VAL SEQRES 1 B 302 PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL GLU GLY SEQRES 2 B 302 CYS MET VAL GLN VAL THR CYS GLY THR THR THR LEU ASN SEQRES 3 B 302 GLY LEU TRP LEU ASP ASP VAL VAL TYR CYS PRO ARG HIS SEQRES 4 B 302 VAL ILE CYS THR SER GLU ASP ILE LEU ASN PRO ASN TYR SEQRES 5 B 302 GLU ASP LEU LEU ILE ARG LYS SER ASN HIS ASN PHE LEU SEQRES 6 B 302 VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL ILE GLY HIS SEQRES 7 B 302 SER MET GLN ASN CYS VAL LEU LYS LEU LYS VAL ASP THR SEQRES 8 B 302 ALA ASN PRO LYS THR PRO LYS TYR LYS PHE VAL ARG ILE SEQRES 9 B 302 GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS TYR ASN SEQRES 10 B 302 GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET ARG PRO SEQRES 11 B 302 ASN PHE THR ILE LYS GLY SER PHE LEU ASN GLY SER CYS SEQRES 12 B 302 GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS VAL SER SEQRES 13 B 302 PHE CYS TYR MET HIS HIS MET GLU LEU PRO THR GLY VAL SEQRES 14 B 302 HIS ALA GLY THR ASP LEU GLU GLY ASN PHE TYR GLY PRO SEQRES 15 B 302 PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY THR ASP SEQRES 16 B 302 THR THR ILE THR VAL ASN VAL LEU ALA TRP LEU TYR ALA SEQRES 17 B 302 ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN ALA ARG SEQRES 18 B 302 THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA MET LYS SEQRES 19 B 302 TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL ASP ILE SEQRES 20 B 302 LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA VAL LEU SEQRES 21 B 302 ASP MET CYS ALA SER LEU LYS GLU LEU LEU GLN ASN GLY SEQRES 22 B 302 MET ASN GLY ARG THR ILE LEU GLY SER ALA LEU LEU GLU SEQRES 23 B 302 ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN CYS SER SEQRES 24 B 302 GLY VAL VAL HET XIU B 401 32 HETNAM XIU 2-(BENZOTRIAZOL-1-YL)-~{N}-[(3-CHLOROPHENYL)METHYL]- HETNAM 2 XIU ~{N}-[4-(1~{H}-IMIDAZOL-5-YL)PHENYL]ETHANAMIDE HETSYN XIU CCF0058981 FORMUL 3 XIU C24 H19 CL N6 O FORMUL 4 HOH *170(H2 O) HELIX 1 AA1 SER A 10 GLY A 15 1 6 HELIX 2 AA2 HIS A 41 CYS A 44 5 4 HELIX 3 AA3 GLU A 47 ASN A 51 5 5 HELIX 4 AA4 ASN A 53 ARG A 60 1 8 HELIX 5 AA5 SER A 62 HIS A 64 5 3 HELIX 6 AA6 ILE A 200 ASN A 214 1 15 HELIX 7 AA7 THR A 226 TYR A 237 1 12 HELIX 8 AA8 THR A 243 LEU A 250 1 8 HELIX 9 AA9 LEU A 250 GLY A 258 1 9 HELIX 10 AB1 ALA A 260 GLY A 275 1 16 HELIX 11 AB2 THR A 292 CYS A 300 1 9 HELIX 12 AB3 SER B 10 GLY B 15 1 6 HELIX 13 AB4 HIS B 41 CYS B 44 5 4 HELIX 14 AB5 GLU B 47 ASN B 51 5 5 HELIX 15 AB6 ASN B 53 ARG B 60 1 8 HELIX 16 AB7 SER B 62 HIS B 64 5 3 HELIX 17 AB8 ILE B 200 ASN B 214 1 15 HELIX 18 AB9 THR B 226 TYR B 237 1 12 HELIX 19 AC1 THR B 243 LEU B 250 1 8 HELIX 20 AC2 LEU B 250 GLY B 258 1 9 HELIX 21 AC3 ALA B 260 GLY B 275 1 16 HELIX 22 AC4 THR B 292 CYS B 300 1 9 SHEET 1 AA1 7 VAL A 73 LEU A 75 0 SHEET 2 AA1 7 PHE A 66 ALA A 70 -1 N VAL A 68 O LEU A 75 SHEET 3 AA1 7 MET A 17 CYS A 22 -1 N THR A 21 O LEU A 67 SHEET 4 AA1 7 THR A 25 LEU A 32 -1 O GLY A 29 N VAL A 18 SHEET 5 AA1 7 VAL A 35 PRO A 39 -1 O TYR A 37 N LEU A 30 SHEET 6 AA1 7 VAL A 86 VAL A 91 -1 O LEU A 87 N CYS A 38 SHEET 7 AA1 7 VAL A 77 GLN A 83 -1 N SER A 81 O LYS A 88 SHEET 1 AA2 5 LYS A 100 PHE A 103 0 SHEET 2 AA2 5 CYS A 156 GLU A 166 1 O PHE A 159 N LYS A 102 SHEET 3 AA2 5 VAL A 148 ASP A 153 -1 N ASN A 151 O SER A 158 SHEET 4 AA2 5 THR A 111 TYR A 118 -1 N SER A 113 O PHE A 150 SHEET 5 AA2 5 SER A 121 ALA A 129 -1 O SER A 123 N ALA A 116 SHEET 1 AA3 3 LYS A 100 PHE A 103 0 SHEET 2 AA3 3 CYS A 156 GLU A 166 1 O PHE A 159 N LYS A 102 SHEET 3 AA3 3 HIS A 172 THR A 175 -1 O ALA A 173 N MET A 165 SHEET 1 AA4 7 VAL B 73 LEU B 75 0 SHEET 2 AA4 7 PHE B 66 ALA B 70 -1 N VAL B 68 O LEU B 75 SHEET 3 AA4 7 MET B 17 CYS B 22 -1 N THR B 21 O LEU B 67 SHEET 4 AA4 7 THR B 25 LEU B 32 -1 O LEU B 27 N VAL B 20 SHEET 5 AA4 7 VAL B 35 PRO B 39 -1 O TYR B 37 N LEU B 30 SHEET 6 AA4 7 VAL B 86 VAL B 91 -1 O LEU B 89 N VAL B 36 SHEET 7 AA4 7 VAL B 77 GLN B 83 -1 N ILE B 78 O LYS B 90 SHEET 1 AA5 5 TYR B 101 PHE B 103 0 SHEET 2 AA5 5 CYS B 156 GLU B 166 1 O PHE B 159 N LYS B 102 SHEET 3 AA5 5 VAL B 148 ASP B 153 -1 N ASN B 151 O SER B 158 SHEET 4 AA5 5 THR B 111 TYR B 118 -1 N SER B 113 O PHE B 150 SHEET 5 AA5 5 SER B 121 ALA B 129 -1 O CYS B 128 N PHE B 112 SHEET 1 AA6 3 TYR B 101 PHE B 103 0 SHEET 2 AA6 3 CYS B 156 GLU B 166 1 O PHE B 159 N LYS B 102 SHEET 3 AA6 3 HIS B 172 THR B 175 -1 O ALA B 173 N MET B 165 CRYST1 55.149 97.960 58.502 90.00 107.78 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018133 0.000000 0.005815 0.00000 SCALE2 0.000000 0.010208 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017951 0.00000